xylazine has been researched along with butylscopolammonium bromide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Ekiri, AB; Grosche, A; Morton, AJ; Varney, CR | 1 |
| Piccinno, M; Rizzo, A; Sciorsci, RL | 1 |
1 trial(s) available for xylazine and butylscopolammonium bromide
| Article | Year |
|---|---|
Cardiovascular effects of N-butylscopolammonium bromide and xylazine in horses.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Butylscopolammonium Bromide; Cross-Over Studies; Female; Heart Rate; Horse Diseases; Horses; Hypnotics and Sedatives; Parasympatholytics; Time Factors; Xylazine | 2011 |
2 other study(ies) available for xylazine and butylscopolammonium bromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Scopolamine butylbromide decreases the xylazine-mediated contractility in bovine pregnant uteri.
Topics: Animals; Butylscopolammonium Bromide; Cattle; Female; In Vitro Techniques; Muscarinic Antagonists; Muscle Relaxants, Central; Pregnancy; Uterine Contraction; Uterus; Xylazine | 2018 |